JFL Life Sciences Limited IPO: Details, Review, Allotment date and Subscription Status

jfl life sciences limited ipo Review, allotment date, subscription and grey market premium(gmp)
  • tbIn hidden
  • id=
  • fTabs-2
  • name=
  • postTabs
  • type=
  • radio
  • >
  • tbIn hidden
  • id=
  • fTabs-3
  • name=
  • postTabs
  • type=
  • radio
  • >
  • tbIn hidden
  • id=
  • fTabs-4
  • name=
  • postTabs
  • type=
  • radio
  • >
  • tbIn hidden
  • id=
  • fTabs-5
  • name=
  • postTabs
  • type=
  • radio
  • >
  • tbHd scrlH
  • >
  • IPO Details
  • >
  • GMP and Review
  • >
  • IPO TimeTable
  • >
  • Subscription (Live)
  • >
  • Allotment Status
  • >
  • tbCn table
  • >
  • idetail
  • class=
  • tbText-1
  • >

    Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS). The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World. JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.

  • tr-caption-container
  • >
  • </li
  • jfl life sciences limited ipo, jfl life sciences limited ipo details, jfl life sciences limited ipo time table, jfl life sciences limited ipo gmp, jfl life sciences limited ipo grey market premium, jfl life sciences limited ipo subscription, jfl life sciences limited ipo allotment status, jfl life sciences limited ipo allotment link
  • class=
  • full
  • src=
  • https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhRrc_VnW_VwrZGEnXYSh9TKe5PnxZRWkkBgnaZ0RJLaJk6mQg9nBLkE-Pi2GSUNiTB3LjGF-3rMgqGis_ypd5OD5IlqK2xDEF-B3beAgExuTOp0Lrdrf3mZ4geJ6bUD48HFqrIcYHe41Gug6QM9jH1vkvuOofe09dxt0lFMvYVqTLI2AP-bSbqnJG7MQ/s1600/jfl-life-scienc-ipo-review-date-gmp-subscription-allotment-status.webp
  • >
  • cap
  • class=
  • tr-caption
  • >jfl life sciences limited ipo Review, allotment date, subscription and grey market premium(gmp)
  • discount
  • style=
  • display: none;
  • >
  • display: none;
  • >
  • emp
  • style=
  • display: none;
  • >
  • otr
  • >
  • iname
  • >JFL Life Sciences Limited IPO Details
  • IPO Size:
  • ipo ipsize
  • >2978000 Equity Shares
    (aggregating up to
  • ipo size
  • >₹18.17 Crore)
  • Bid Lot:
  • ipo minlot
  • >2000 Equity Shares and in Multiples thereof
  • Price Band:
  • ipo imin
  • >₹61.00
  • Minimum Bid Lot:
  • ipo
  • > 1 Lot (
  • minlot
  • >2000 Equity Shares)
  • Minimum Bid Amount (in Rs.):
  • ipo minrs
  • >₹1,22,000.00 at cut-off price.
  • Maximum Bid Lot:
  • ipo imaxl
  • >upto Rs.200000 Lot (
  • maxes
  • >8000 Equity Shares)
  • Maximum Bid Amount (in Rs.):
  • ipo maxrs
  • >₹NaN at cut-off price.
  • Discount:
  • ipo
  • id=
  • idisc
  • >10.00
  • Name of the Registrar:
  • reg
  • class=
  • ipo
  • >KFin Technologies Limited
  • Allotment Link:
  • link
  • class=
  • ipo
  • >https://ris.kfintech.com/ipostatus/
  • Listing on: NSE
    Face Value:
  • ipo
  • id=
  • iface
  • >10
  • Retail Quota: Not less than
  • ipo irquote
  • >50% of the Net Issue
  • NII Quota: Not less than
  • ipo inquote
  • >50% of the Net Issue
  • Emp Quota: Not less than
  • ipo iequote
  • >0% of the Net Issue
  • Emp Quota: Not less than
  • ipo iequote
  • >0% of the Net Issue
  • Listing Name:
  • ipo
  • id=
  • liname
  • >JFLLIFE
  • 2
  • >Above information source:
  • https://www.sebi.gov.in/index.html
  • target=
  • _blank
  • >SEBI official site.
  • tbText-2
  • >
  • table
  • >
  • gmp
  • >
  • g
  • >
  • c
  • >
  • c
  • >
  • iname
  • >JFL Life Sciences Limited IPO Review and GMP (Grey market premium) Today and Kostak Price Live
  • Company Name GMP(grey market Premium) Kostak Price
  • 3
  • >
  • extL
  • href=
  • https://www.moneytant.com/p/latest-ipo-gmp-grey-market-premium-today.html
  • >ALL IPO GMP (grey market premium) Today and Kostak Price
  • 3
  • >Disclaimer: Stock Market investments are subject to market risks, read all scheme related documents carefully before investing. All the information provided on our IPO Portal is for Reaserch purpose only. I do not claim any facts, and figure mentioned here.
    Source: SmartInvestment
  • JFL Life Sciences Limited IPO Review

  • Issue Opens on 25nd August & Closes on 30th August 2022
  • Object of the issue : Repayment of secured and unsecured loans, Funding the working capital requirements of the company and General Corporate Purposes
  • Issue Size : 29,78,000 Equity Share (Rs. 18.17 Cr.)
  • Face Value Rs. 10
  • Offer price Rs. 61.00
  • Minumum Lot Size : 2000 Share
  • Listing on : NSE SME Platform
  • BRLM : GYR Capital Advisors Limited
  • Registrar : KFin Technologies Limited
  • Company Management : Smiral Ashwinkumar Patel, Tejal Smiral Patel
  • Market Cap : Rs. 67.09 Cr.
  • Pre Issue Promoter Holding : 92.52%
  • Post Issue Promoter holding : 62%
  • Issue constitutes 27.08% of the post issue paid up capital
  • Average of last 3 Yrs. EPS Rs. 0.76& RONW : 7.18%
  • Pre IPO Eq. Capital Rs. : 8.02 Cr.
  • Post IPO Eq. Capital Rs.11 Cr.
  • Pre IPO : P/BV Ratio 4.46 (NAV : 13.67)
  • Post Issue : P/BV Ratio : 2.30 (NAV : 26.48)
  • Post IPO asking P/E on fully diluted equity : 26.52
  • BRLM’s Performance : This is 6th Issue from BRLM in last 2 years. In last 4 Listing : 4 Issued opened with premium & 2 Issue Discount.
  • OTHER SIDE OF THE COIN

  • The average cost of acquisition of equity shares by the promoter is Rs. 9 and Rs. 9.31 per share and offer price is Rs. 61 per share.
  • It has issued bonus shares in the ratio of 12:1 in January 2022 before filing DRHP
  • Apart from initial equity capital at par, the company issued further equity shares at the price range of Rs. 91 to 130 before march 2013 and January 2021
  • On financial front revenue almost remained static from 2019 to 2021 and down in 2022. However with lower revenue in 2022 profit has incurred five times.
  • It depends on few customers. Top 10 customers contributed 91.5% revenue.
  • It requires significant amount of working capital.
  • Company operated in competitive business environment
  • Recommendation : It has posted static revenue from 2019 to 2021 and down in 2022. However reported consistent growth in bottom lines from 2019 to 11MFY22. On valuation front issue is fully priced but considering expansion attractive margins, fancy in pharma segment, investors may apply for long term prospectiv

  • tbText-3
  • >
  • table
  • >

  • iname
  • >JFL Life Sciences Limited IPO Timetable
  • IPO Open:
  • ipo iopn
  • >25 Aug 2022
  • IPO Close:
  • ipo
  • id=
  • icls
  • >30 Aug 2022
  • Modification Period: Post Issue Modification on
  • ipo
  • id=
  • modate
  • >01 Sep 2022 from 10.00 am to 11.00 am
  • Cut-off time for UPI Mandate Confirmation:
  • ipo
  • id=
  • umdate
  • >01 Sep 2022 from 10.00 am to 11.00 am
  • Allotment Date:
  • alot
  • class=
  • ipo ialot
  • >05 Sep 2022
  • Refunds Date:
  • ipo
  • id=
  • irfnd
  • >06 Sep 2022
  • Credit of Shares to Demat Account:
  • ipo
  • id=
  • icod
  • >07 Sep 2022
  • IPO Listing Date:
  • ipo ilist
  • >08 Sep 2022
  • 2
  • >Above information source:
  • https://www.sebi.gov.in/index.html
  • target=
  • _blank
  • >SEBI official site.
  • tbText-4
  • >
  • table
  • >
  • emp
  • style=
  • display: none;
  • >
  • otr
  • >
  • Check
  • iname
  • >JFL Life Sciences Limited NSE IPO subscription status live start on:
  • ipo iopn
  • >25 Aug 2022
  • NSE:
    QIB (in Equity Share)
  • qbs
  • >-
  • NII (in Equity Share)
  • nbs
  • >-
  • Retail (in Equity Share)
  • rbs
  • >-
  • Employee (in Equity Share)
  • ebs
  • >-
  • Others (in Equity Share)
  • obs
  • >-
  • Total (in Equity Share)
  • tbs
  • >-
  • 6
  • >Information source:
  • https://www.nseindia.com/
  • target=
  • _blank
  • >NSE official site.
  • iname
  • >JFL Life Sciences Limited Company issue offer
  • ipsize ipo
  • >2978000 Equity Shares (Approximately up to
  • ipo size
  • >₹18.17 Crore) IPO was subscribed more than
  • ttst
  • > times on the this day of the bidding process. Bids were received for
  • nsb
  • > crore equity shares against an offer size of
  • ipo
  • id=
  • nsr
  • > equity stocks as per National stock Exchange (NSE).

    The portion reserved for retail investors was subscribed

  • ipo
  • id=
  • rtst
  • > times, qualified institutional buyers category was subscribed
  • ipo
  • id=
  • qtst
  • > times and non-institutional category received
  • ipo
  • id=
  • ntst
  • > times subscription.

    Price band has been fixed at

  • imin ipo
  • >₹61.00 per equity share for the initial share-sale.

  • tbText-5
  • >

    Where to check ipo allotment status for
  • iname
  • >JFL Life Sciences Limited?
  • After garnering a massive response from investors, the Initial public offering (IPO) of

  • iname ipo
  • >JFL Life Sciences Limited is likely to be up for allotment on
  • ialot ipo
  • >05 Sep 2022 day.

  • demo
  • class=
  • button ln
  • >
  • >Check IPO Allotment
  • There are two official way to check

  • iname ipo
  • >JFL Life Sciences Limited IPO allotment status,

    1. BSE official site
    2. IPO registrar's website
  • Post a Comment

    BSE:
    NSE: